How to buy Abbott Laboratories shares

Abbott Laboratories (ABT) is a publicly traded medical devices business based in the US which employs around 114,000 staff. Abbott Laboratories is listed on the NYSE and traded in US dollars. Its current price of $131.99 is 4.0% up on its price a month ago ($126.88).

Our top picks for where to buy Abbott Laboratories shares

Best for 0% commission stocks

Finder Award

Go to site

Capital at risk. T&Cs apply.

Copy picks from top traders

Commission-free trades
Fractional shares
Get dividend payments

Best for international trading

Go to site

Capital at risk. T&Cs apply.

Up to 8.5% interest on uninvested cash

11,000+ stocks & ETFs
Commission-free investing
Advanced trading tools

Best for fractional shares

Go to site

Capital at risk. T&Cs apply.

Earn 4.5% on uninvested funds

Commission-free trades
Fractional shares
5,400+ stocks/ETFs

Abbott Laboratories stock chart

Fees calculator for buying Abbott Laboratories shares with popular apps

Find the cheapest way to buy Abbott Laboratories shares with our calculator. Bear in mind that both exchange rates and share prices fluctuate in real time, so the costs estimated here are just a guide (refer to platforms themselves for availability and exact pricing).

Quantity of shares

Platform	Finder Score	Account fee	Min. initial deposit	Trade cost	Link
	9 Excellent	£0	$100	£995.75	Go to siteCapital at risk
	9.1 Excellent	£0	£0	£998.13	Go to siteCapital at risk
	9 Excellent	From £0	£0	£995.26	Go to siteCapital at risk
	8.8 Great	£0	£0	£988.64	Go to siteCapital at risk
	9.2 Excellent	£0	£0	£993.28	Go to siteCapital at risk
	8.5 Great	£0 (0.45% for funds)	£1	£1,010.17	Go to siteCapital at risk

Full comparison of share dealing platforms

Alternative ways to invest in Abbott Laboratories

• Via a fund
• Via an S&P 500 ETF

Buying shares in just one company is generally considered a riskier bet than investing in a range of investments - AKA a "diversified portfolio". Experts generally recommend holding a mix of investments in specific assets and funds. Funds are ready-made portfolios of multiple companies' shares (potentially including Abbott Laboratories), and the idea is that drops in the value of one constituent company's share price might be offset by rises in others.

Abbott Laboratories is a major part of the NYSE, so it's included in many global funds and investment trusts, as well as tracker-style exchange traded funds (ETFs).

ETF	Icon	1-year performance (to May. '25)	5-year performance (to May. '25)	Link
Invesco S&P 500 ETF (SPXP)		6.95%	105.68%	Invest Capital at risk
Xtrackers S&P 500 Swap ETF 1C (XSPX)		6.90%	105.12%	Invest Capital at risk
iShares Core S&P 500 ETF USD (Acc) (CSP1)		6.75%	103.55%	Invest Capital at risk
HSBC S&P 500 ETF (HSPX)		5.70%	92.03%	Invest Capital at risk

Boost your investment IQ!

Subscribe now for market insights, expert advice and a chance to win £800! (T&Cs)

Sign uploading

Winners | Emails | Unsubscribe | Privacy

Is it a good time to buy Abbott Laboratories stock?

Review technicals and fundamentals to help you determine if now's a good time for you to invest.

Technical analysis

View Abbott Laboratories's price performance, share price volatility, historical data and technicals.

• Quick verdict
• Historical data

Invest in Abbott Laboratories shares

Finder AwardFree Trades

• Over 5,500+ stocks from 20 exchanges
• Free to open an account
• Commission-free trading

Go to site

Capital at risk

Frequently asked questions

• Does Abbott Laboratories pay dividends?

  • Dividend yield
  • Forward yield
  • Payout ratio

  Dividend yield: 1.76% of stock value

  Forward annual dividend yield: 1.76% of stock value

  Dividend payout ratio: 47.7% of net profits

  Abbott Laboratories has recently paid out dividends equivalent to 1.76% of its share value annually.

  Abbott Laboratories has paid out, on average, around 47.7% of recent net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.76% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), shareholders could enjoy a 1.76% return on their shares, in the form of dividend payments. In Abbott Laboratories's case, that would currently equate to about 2.28 per share.

  While Abbott Laboratories's payout ratio might seem fairly standard, it's worth remembering that it may be investing much of the rest of its net profits in future growth.

  Abbott Laboratories's next dividend payout is expected around 14 May 2025. To be eligible for the latest dividend you would need to have been a shareholder at 14 April 2025 (the "ex-dividend date").

  Abbott Laboratories's dividend yield is perhaps best considered in relation to those of similar companies.

  • Pfizer (PFE.US): 7.23% (7.23% forward annual dividend yield)
  • Gilead Sciences (GILD.US): 3.07% (3.07% forward annual dividend yield)
  • Johnson-and-Johnson (JNJ.US): 3.37% (3.37% forward annual dividend yield)
  • IDEXX Laboratories (IDXX.US): (does not pay dividend)
  • GlaxoSmithKline (GSK.LSE): 4.64% (4.64% forward annual dividend yield)
  • AstraZeneca (AZN.LSE): 2.34% (2.34% forward annual dividend yield)

• When does the fiscal year end for Abbott Laboratories?

  Abbott Laboratories's fiscal year ends in December.

• Where is Abbott Laboratories based?

  Abbott Laboratories's address is: 100 Abbott Park Road, North Chicago, IL, United States, 60064-6400

• Have Abbott Laboratories's shares ever split?

  Abbott Laboratories's shares were split on a 10000:4798 basis on 1 January 2013. So if you had owned 4798 shares the day before before the split, the next day you'd have owned 10000 shares. This wouldn't directly have changed the overall worth of your Abbott Laboratories shares – just the quantity. However, indirectly, the new 52% lower share price could have impacted the market appetite for Abbott Laboratories shares which in turn could have impacted Abbott Laboratories's share price.

• How to sell Abbott Laboratories shares

  It's as easy to sell Abbott Laboratories as it is to buy! Here's how to sell Abbott Laboratories shares that you already own.

  1. Open your investment app. If you've got one with desktop access, you can log in online
  2. Go to your portfolio. This should be in the main menu
  3. Find your shares. You may be able to search your portfolio
  4. Choose how many you'd like to sell. You'll be able to review the price and see how much you'll receive
  5. Sell your Abbott Laboratories shares. Your investment platform will let you know when your shares are sold

• Can you buy Abbott Laboratories shares with a debit card?

  Most dealing providers will let you use your debit card to top up your account and buy shares. The main ways are with a debit card, bank transfer or with Apple/Google Pay.

• What's the easiest way to buy Abbott Laboratories shares?

  The easiest way to get hold of some Abbott Laboratories shares is to sign up for a share trading app and place a market order or basic order. This type of order tells the platform that you're interested, so it'll try to execute it as quickly as it can. It could take some time for the order to go through, especially if there's a lot of volatility in Abbott Laboratories shares.

• Do you need to complete a W8-BEN form if you want to invest in Abbott Laboratories

  Yes. When you investing in a US stock, you need to complete a W8-BEN form to minimise your tax liability. Whether these are automatically handled for you depends on your broker, so it would be a good idea to check with them directly.

• What is the key financial information for Abbott Laboratories?

  Abbott Laboratories financials

  Revenue TTM	$42.3 billion
  Operating margin TTM	18.09%
  Gross profit TTM	$23.7 billion
  Return on assets TTM	6.38%
  Return on equity TTM	30.65%
  Profit margin	31.89%
  Book value	$28.06
  Market capitalisation more info button	$233.1 billion

  TTM: trailing 12 months

Ready to compare platforms?

Get started